<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nuc</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник НЯЦ РК</journal-title><trans-title-group xml:lang="en"><trans-title>NNC RK Bulletin</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1729-7516</issn><issn pub-type="epub">1729-7885</issn><publisher><publisher-name>Национальный ядерный центр Республики Казахстан</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52676/1729-7885-2026-1-198-206</article-id><article-id custom-type="elpub" pub-id-type="custom">nuc-1004</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>СРАВНИТЕЛЬНЫЙ АНАЛИЗ ДОЗОВЫХ РАСПРЕДЕЛЕНИЙ И ОРГАННЫХ ДОЗ ПРИ 3D-CRT, IMRT И VMAT В СООТВЕТСТВИИ С ПРОТОКОЛАМИ QUANTEC И RTOG: ОСОБЕННОСТИ ПЛАНИРОВАНИЯ, ПРЕИМУЩЕСТВА И ОГРАНИЧЕНИЯ</article-title><trans-title-group xml:lang="en"><trans-title>COMPARATIVE ANALYSIS OF DOSE DISTRIBUTIONS AND ORGAN DOSES IN 3D-CRT, IMRT AND VMAT ACCORDING TO QUANTEC AND RTOG PROTOCOLS: PLANNING FEATURES, ADVANTAGES AND LIMITATIONS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-3700-9812</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мергенбаева</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Mergenbayeva</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Медицинский физик</p><p>Семей</p></bio><bio xml:lang="en"><p>Semey</p></bio><email xlink:type="simple">inur.mergenbayeva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0379-5315</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Танатаров</surname><given-names>С. З.</given-names></name><name name-style="western" xml:lang="en"><surname>Tanatarov</surname><given-names>S. Z.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Директор</p><p>Семей</p></bio><bio xml:lang="en"><p>Semey</p></bio><email xlink:type="simple">sayat68@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-4893-9264</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Идинов</surname><given-names>М. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Idinov</surname><given-names>M. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Главный инженер</p><p>Семей</p></bio><bio xml:lang="en"><p>Semey</p></bio><email xlink:type="simple">idinov_medet@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4553-356X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кенжина</surname><given-names>Л. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Kenzhina</surname><given-names>L. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Советник по науке</p><p>Семей</p></bio><bio xml:lang="en"><p>Semey</p></bio><email xlink:type="simple">laurakenzhina@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-0004-8354</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Атантаева</surname><given-names>Б. Ж.</given-names></name><name name-style="western" xml:lang="en"><surname>Atantayeva</surname><given-names>B. Zh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Заместитель директора</p><p>Семей</p></bio><bio xml:lang="en"><p>Semey</p></bio><email xlink:type="simple">bayan_atantaeva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-4069-889X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Айткалиев</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Aitkaliyev</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Заведующий отделением медицинских физиков</p><p>Семей</p></bio><bio xml:lang="en"><p>Semey</p></bio><email xlink:type="simple">seka_asm@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-8621-9381</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алибекова</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Alibekova</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Медицинский физик</p><p>Семей</p></bio><bio xml:lang="en"><p>Semey</p></bio><email xlink:type="simple">aigul-aiko@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-3782-2693</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тусупова</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Tussupova</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Медицинский физик</p><p>Семей</p></bio><bio xml:lang="en"><p>Semey</p></bio><email xlink:type="simple">tusupova.83@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-2171-9037</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елемесова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Elemessova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Медицинский физик</p><p>Семей</p></bio><bio xml:lang="en"><p>Semey</p></bio><email xlink:type="simple">elemesovanazgul1996@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-6660-8848</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сабеков</surname><given-names>Е. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Sabekov</surname><given-names>E. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Врач-радиолог</p><p>Семей</p></bio><bio xml:lang="en"><p>Semey</p></bio><email xlink:type="simple">isabek.erganat.67@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">КГП «Центр ядерной медицины и онкологии» УЗ области Абай<country>Казахстан</country></aff><aff xml:lang="en">“Center of Nuclear Medicine and Oncology” of Abay Regional Health Department<country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>25</day><month>04</month><year>2026</year></pub-date><volume>0</volume><issue>1</issue><fpage>198</fpage><lpage>206</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мергенбаева А.Д., Танатаров С.З., Идинов М.Т., Кенжина Л.Б., Атантаева Б.Ж., Айткалиев С.М., Алибекова А.Д., Тусупова А.Д., Елемесова Н.А., Сабеков Е.О., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Мергенбаева А.Д., Танатаров С.З., Идинов М.Т., Кенжина Л.Б., Атантаева Б.Ж., Айткалиев С.М., Алибекова А.Д., Тусупова А.Д., Елемесова Н.А., Сабеков Е.О.</copyright-holder><copyright-holder xml:lang="en">Mergenbayeva A.D., Tanatarov S.Z., Idinov M.T., Kenzhina L.B., Atantayeva B.Z., Aitkaliyev S.M., Alibekova A.D., Tussupova A.D., Elemessova N.A., Sabekov E.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journals.nnc.kz/jour/article/view/1004">https://journals.nnc.kz/jour/article/view/1004</self-uri><abstract><p>Исследование выполнено на базе Центра ядерной медицины и онкологии (г. Семей) и посвящено сравнительному дозиметрическому анализу параметров планирования дистанционной лучевой терапии при местно-распространённом раке шейки матки. Проведено сопоставление трёхмерной конформной лучевой терапии (3D-CRT), лучевой терапии с модуляцией интенсивности (IMRT) и объёмно-модулированной дуговой терапии (VMAT) с точки зрения качества дозовых распределений и дозовой нагрузки на органы риска. Планирование выполнено для 25 пациенток с использованием линейного ускорителя TrueBeam с ежедневной верификацией укладки на основе IGRT/CBCT. Качество планов оценивали по данным дозово-объёмных гистограмм с использованием параметров D95% для PTV, индексов конформности (CI) и гомогенности (HI), а также абсолютных дозовых характеристик (Dmean, Dmax) для органов риска в сопоставлении с рекомендациями протоколов RTOG и QUANTEC. Анализ показал, что методика VMAT продемонстрировала наилучшие дозиметрические показатели с высоким индексом конформности CI = 1,03±0,02 и низким индексом гомогенности HI = 0,09±0,02, обеспечивая более равномерное и точное покрытие PTV по сравнению с IMRT и 3D-CRT. Ключевым результатом стало существенное снижение дозовой нагрузки на органы риска малого таза: при использовании VMAT суммарное снижение дозы составило в среднем 25–30% относительно 3D-CRT, при этом средняя доза на прямую кишку (Dmean) снизилась до 33,0 Гр. Дополнительным пре- имуществом VMAT явилось сокращение среднего времени сеанса облучения до 5–7 минут, что снижает риск внутрифракционных смещений. Полученные данные подтверждают дозиметрические преимущества VMAT и обосновывают целесообразность её применения в условиях регионального онкологического центра.</p></abstract><trans-abstract xml:lang="en"><p>The study was conducted at the Center of Nuclear Medicine and Oncology (Semey) and is devoted to a comparative dosimetric analysis of external beam radiotherapy planning parameters for locally advanced cervical cancer. Three- dimensional conformal radiotherapy (3D-CRT), intensity-modulated radiation therapy (IMRT), and volumetric modulated arc therapy (VMAT) were compared in terms of dose distribution quality and dose burden to organs at risk. Treatment planning was performed for 25 patients using a TrueBeam linear accelerator with daily patient setup verification based on IGRT/CBCT. Plan quality was evaluated using dose–volume histograms, including D95% for the planning target volume (PTV), conformity index (CI) and homogeneity index (HI), as well as absolute dose parameters (Dmean, Dmax) for organs at risk, in accordance with RTOG criteria and QUANTEC recommendations. The analysis demonstrated that VMAT provided the most favorable dosimetric performance, with a high conformity index (CI = 1,03±0,02) and a low homogeneity index (HI = 0,09±0,02), ensuring more uniform and accurate PTV coverage compared with IMRT and 3D-CRT. A key finding was a substantial reduction in dose burden to pelvic organs at risk: VMAT resulted in an average 25–30% reduction in overall dose compared with 3D-CRT, while the mean dose to the rectum (Dmean) decreased to 33,0 Gy. In addition, VMAT significantly reduced the average treatment delivery time to 5–7 minutes, thereby lowering the risk of intrafraction motion. The obtained results confirm the dosimetric advantages of VMAT and substantiate its feasibility for routine clinical use in a regional oncology center.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак шейки матки</kwd><kwd>дистанционная лучевая терапия</kwd><kwd>дозовое планирование</kwd><kwd>3D-CRT</kwd><kwd>IMRT</kwd><kwd>VMAT</kwd><kwd>дозовое распределение</kwd><kwd>органы риска</kwd><kwd>индекс конформности</kwd><kwd>QUANTEC</kwd><kwd>RTOG</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cervical cancer</kwd><kwd>external beam radiotherapy</kwd><kwd>dose planning</kwd><kwd>3D-CRT</kwd><kwd>IMRT</kwd><kwd>VMAT</kwd><kwd>dose distribution</kwd><kwd>organs at risk</kwd><kwd>conformity index</kwd><kwd>QUANTEC</kwd><kwd>RTOG</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries // CA Cancer Journal for Clinicians. – 2021. – Vol. 71, No. 3. – P. 209– 249. – https://doi.org/10.3322/caac.21660</mixed-citation><mixed-citation xml:lang="en">Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries // CA Cancer Journal for Clinicians. – 2021. – Vol. 71, No. 3. – P. 209– 249. – https://doi.org/10.3322/caac.21660</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Yao G., Qiu J., Zhu F., Wang X. Survival of Patients with Cervical Cancer Treated with Definitive Radiotherapy or Concurrent Chemoradiotherapy According to Histological Subtype: A Systematic Review and Meta-Analysis // Frontiers in Medicine (Lausanne). – 2022. – Vol. 9. – Art. 843262. – https://doi.org/10.3389/fmed.2022.843262</mixed-citation><mixed-citation xml:lang="en">Yao G., Qiu J., Zhu F., Wang X. Survival of Patients with Cervical Cancer Treated with Definitive Radiotherapy or Concurrent Chemoradiotherapy According to Histological Subtype: A Systematic Review and Meta-Analysis // Frontiers in Medicine (Lausanne). – 2022. – Vol. 9. – Art. 843262. – https://doi.org/10.3389/fmed.2022.843262</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Pritanjali S., Rajhans K., Amrita R. Dosimetric Comparison of 3-Dimensional Conformal Radiotherapy (3DCRT), Intensity Modulated Radiotherapy (IMRT) and Volumetric-Arc Radiotherapy (VMAT) in Cervical Cancer Treatment // Annals of Radiation Therapy and Oncology. – 2023. – Vol. 4, Issue 1. – Art. 1022.</mixed-citation><mixed-citation xml:lang="en">Pritanjali S., Rajhans K., Amrita R. Dosimetric Comparison of 3-Dimensional Conformal Radiotherapy (3DCRT), Intensity Modulated Radiotherapy (IMRT) and Volumetric-Arc Radiotherapy (VMAT) in Cervical Cancer Treatment // Annals of Radiation Therapy and Oncology. – 2023. – Vol. 4, Issue 1. – Art. 1022.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dröge L.H., von Sivers F.F., Schirmer M.A., Wolff H.A. Conventional 3D conformal radiotherapy and volumetric modulated arc therapy for cervical cancer: Comparison of clinical results with special consideration of the influence of patientand treatment-related parameters // Strahlentherapie und Onkologie. – 2021. – Vol. 197, No. 6. – P. 520–527. – https://doi.org/10.1007/s00066-021-01782-5</mixed-citation><mixed-citation xml:lang="en">Dröge L.H., von Sivers F.F., Schirmer M.A., Wolff H.A. Conventional 3D conformal radiotherapy and volumetric modulated arc therapy for cervical cancer: Comparison of clinical results with special consideration of the influence of patientand treatment-related parameters // Strahlentherapie und Onkologie. – 2021. – Vol. 197, No. 6. – P. 520–527. – https://doi.org/10.1007/s00066-021-01782-5</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Shen Y., Tang X., Lin S., Jin X., Ding J., Shao M. Automatic dose prediction using deep learning and plan optimization with finite-element control for intensity modulated radiation therapy // Medical Physics. – 2024. – Vol. 51, No. 1. – P. 545–555. – https://doi.org/10.1002/mp.16743</mixed-citation><mixed-citation xml:lang="en">Shen Y., Tang X., Lin S., Jin X., Ding J., Shao M. Automatic dose prediction using deep learning and plan optimization with finite-element control for intensity modulated radiation therapy // Medical Physics. – 2024. – Vol. 51, No. 1. – P. 545–555. – https://doi.org/10.1002/mp.16743</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gazsi I., Marcu L.G. Comparative dosimetric assessment of combined treatment modalities in cervical cancer radiotherapy for optimal organ protection // Radiation and Environmental Biophysics. – 2025. – Vol. 64, No. 2. – P. 291–302. – https://doi.org/10.1007/s00411-025-01113-7</mixed-citation><mixed-citation xml:lang="en">Gazsi I., Marcu L.G. Comparative dosimetric assessment of combined treatment modalities in cervical cancer radiotherapy for optimal organ protection // Radiation and Environmental Biophysics. – 2025. – Vol. 64, No. 2. – P. 291–302. – https://doi.org/10.1007/s00411-025-01113-7</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dose management systems – from setting up to quality assurance // IAEA Human Health Series. – Vienna: International Atomic Energy Agency, 2025. – No. 49.</mixed-citation><mixed-citation xml:lang="en">Dose management systems – from setting up to quality assurance // IAEA Human Health Series. – Vienna: International Atomic Energy Agency, 2025. – No. 49.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Marks L.B., Ten Haken R.K., Martel M.K. Guest editor’s introduction to QUANTEC: a user’s guide // International Journal of Radiation Oncology, Biology, Physics. – 2010. – Vol. 76, No. 3 (Suppl.). – P. 1–2. – https://doi.org/10.1016/j.ijrobp.2009.08.075</mixed-citation><mixed-citation xml:lang="en">Marks L.B., Ten Haken R.K., Martel M.K. Guest editor’s introduction to QUANTEC: a user’s guide // International Journal of Radiation Oncology, Biology, Physics. – 2010. – Vol. 76, No. 3 (Suppl.). – P. 1–2. – https://doi.org/10.1016/j.ijrobp.2009.08.075</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Требования к точности и факторы неопределенности в лучевой терапии / МАГАТЭ. – Вена: МАГАТЭ, 2025. – (Серия изданий МАГАТЭ по здоровью человека; № 31).</mixed-citation><mixed-citation xml:lang="en">Accuracy Requirements and Uncertainties in Radiotherapy // IAEA Human Health Series. – Vienna: International Atomic Energy Agency, 2025. – No. 31).]</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mayadev J.S., Albuquerque K.V., Price J.G., Marcrom S., Hrycushko B.A., Horwitz E.M., Panetta J., Stanley D.N., Samanta S., Sabouri P., Liu P.Y., Kohlmyer S., McCann C., Russell K., Moore K.L., Ray X. ARTIA-Cervix: a prospective trial of adaptive radiation therapy for cervical cancer // International Journal of Gynecological Cancer. – 2025. – Vol. 21. – Art. 102823. – https://doi.org/10.1016/j.ijgc.2025.102823</mixed-citation><mixed-citation xml:lang="en">Mayadev J.S., Albuquerque K.V., Price J.G., Marcrom S., Hrycushko B.A., Horwitz E.M., Panetta J., Stanley D.N., Samanta S., Sabouri P., Liu P.Y., Kohlmyer S., McCann C., Russell K., Moore K.L., Ray X. ARTIA-Cervix: a prospective trial of adaptive radiation therapy for cervical cancer // International Journal of Gynecological Cancer. – 2025. – Vol. 21. – Art. 102823. – https://doi.org/10.1016/j.ijgc.2025.102823</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Clark R., Magliari A., Rosa L., Li T., Beriwal S., Cozzi L. Comparison of Advanced Dynamic Arc Therapy with Collimator Rotation and Fixed Integrated Gantry Positions to the Standard of Care Across Five Treatment Sites // Cureus. – 2025. – Vol. 1817, No. 6. – Art. e86280. – https://doi.org/10.7759/cureus.86280</mixed-citation><mixed-citation xml:lang="en">Clark R., Magliari A., Rosa L., Li T., Beriwal S., Cozzi L. Comparison of Advanced Dynamic Arc Therapy with Collimator Rotation and Fixed Integrated Gantry Positions to the Standard of Care Across Five Treatment Sites // Cureus. – 2025. – Vol. 1817, No. 6. – Art. e86280. – https://doi.org/10.7759/cureus.86280</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y., Huang L., Leng Z., Chen M., Zhang J., Chen R., Chen Z., Liu Y., Qi Z., Zhou Q., Deng X., Peng Y. Fully automated intensity-modulated radiotherapy plans for rectal cancer based on deep learning predictions of three-dimensional dose distributions // Quantitative Imaging in Medicine and Surgery. – 2025. – Vol. 15, No. 12. – P. 12482–12496. – https://doi.org/10.21037/qims-2025-168</mixed-citation><mixed-citation xml:lang="en">Liu Y., Huang L., Leng Z., Chen M., Zhang J., Chen R., Chen Z., Liu Y., Qi Z., Zhou Q., Deng X., Peng Y. Fully automated intensity-modulated radiotherapy plans for rectal cancer based on deep learning predictions of three-dimensional dose distributions // Quantitative Imaging in Medicine and Surgery. – 2025. – Vol. 15, No. 12. – P. 12482–12496. – https://doi.org/10.21037/qims-2025-168</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Downes M.H., Olsen V., Williams A., Sheu R., Thor M., Greenwald L., Dumane V., Hsieh K., Ali A., Morgan O., Buckstein M., Marshall D.C. A feasibility study of sexual organ-dose sparing volumetric modulated arc therapy in female low rectal cancer patients treated with three-dimensional conformal radiation therapy // Journal of Applied Clinical Medical Physics. – 2025. – No. 12. – Art. e70394. – https://doi.org/10.1002/acm2.70394</mixed-citation><mixed-citation xml:lang="en">Downes M.H., Olsen V., Williams A., Sheu R., Thor M., Greenwald L., Dumane V., Hsieh K., Ali A., Morgan O., Buckstein M., Marshall D.C. A feasibility study of sexual organ-dose sparing volumetric modulated arc therapy in female low rectal cancer patients treated with three-dimensional conformal radiation therapy // Journal of Applied Clinical Medical Physics. – 2025. – No. 12. – Art. e70394. – https://doi.org/10.1002/acm2.70394</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Small W. Jr., Bosch W.R., Harkenrider M.M., Strauss J.B. [et al.] NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update // International Journal of Radiation Oncology, Biology, Physics. – 2021. – Vol. 109, No. 2. – P. 413–424. – https://doi.org/10.1016/j.ijrobp.2020.08.061</mixed-citation><mixed-citation xml:lang="en">Small W. Jr., Bosch W.R., Harkenrider M.M., Strauss J.B. [et al.] NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update // International Journal of Radiation Oncology, Biology, Physics. – 2021. – Vol. 109, No. 2. – P. 413–424. – https://doi.org/10.1016/j.ijrobp.2020.08.061</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Определение поглощенной дозы при дистанционной лучевой терапии / МАГАТЭ. – Вена: МАГАТЭ, 2025. – (Серия технических докладов; № 398 (Rev. 1)).</mixed-citation><mixed-citation xml:lang="en">Determination of Absorbed Dose in External Beam Radiotherapy // IAEA Technical Reports Series. – Vienna: International Atomic Energy Agency, 2025. – No. 398 (Rev. 1)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
